Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Michaël Pollak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3047-0604; OpenAlex author ID A5005616347. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 3 papers · 2014: 2 papers · 2015: 3 papers · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 16

  1. The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers14225597↗
  2. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Co-author DOI 10.1158/1055-9965.epi-19-1389↗
  3. eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-019-13086-5↗
  4. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking? Co-author DOI 10.1158/1055-9965.epi-16-0891↗
  5. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival. Co-author DOI 10.1245/s10434-017-5988-y↗
  6. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. Co-author DOI 10.1158/0008-5472.can-16-1699↗
  7. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial. First author DOI 10.1016/s1470-2045(15)00027-3↗
  8. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. Co-author DOI 10.1093/aje/kwv041↗
  9. Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms. Co-author DOI 10.2337/db14-1132↗
  10. Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. Co-author DOI 10.1007/s10552-014-0409-z↗
  11. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Co-author DOI 10.1038/nm.3686↗
  12. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. Co-author DOI 10.1093/jnci/djs474↗
  13. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. Co-author DOI 10.1093/jnci/djt123↗
  14. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Co-author DOI 10.1158/1055-9965.epi-12-1458↗
  15. Metformin and pancreatic cancer: a clue requiring investigation. Co-author DOI 10.1158/1078-0432.ccr-12-0694↗
  16. Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies. Co-author DOI 10.1158/1055-9965.epi-10-1024↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rachael Z. Stolzenberg‐Solomon · 7 shared papers, 2011–2020 · strength 0.41
  2. Edward L. Giovannucci · 6 shared papers, 2013–2020 · strength 0.24
  3. JoAnn E. Manson · 6 shared papers, 2013–2020 · strength 0.24
  4. Peter Kraft · 6 shared papers, 2013–2020 · strength 0.24
  5. Brian Matthew Wolpin · 6 shared papers, 2013–2020 · strength 0.24
  6. Charles S. Fuchs · 6 shared papers, 2013–2020 · strength 0.24
  7. Ying Bao · 5 shared papers, 2013–2020 · strength 0.21
  8. Debra T. Silverman · 4 shared papers, 2011–2017 · strength 0.19
  9. Demetrius Albanes · 4 shared papers, 2011–2017 · strength 0.19
  10. Letícia Nogueira · 3 shared papers, 2014–2017 · strength 0.17
  11. Eric J. Jacobs · 3 shared papers, 2014–2017 · strength 0.17
  12. Chen Yuan · 3 shared papers, 2014–2020 · strength 0.16
  13. Stephanie J. Weinstein · 3 shared papers, 2011–2017 · strength 0.15
  14. Maxime Parisotto · 1 shared paper, 2022 · strength 0.14
  15. Andreea R. Schmitzer · 1 shared paper, 2022 · strength 0.14
  16. Gerardo Ferbeyre · 1 shared paper, 2022 · strength 0.14
  17. Ana Babić · 2 shared papers, 2016–2020 · strength 0.13
  18. Kimmie Ng · 2 shared papers, 2016–2020 · strength 0.13
  19. Laufey Thora Amundadottir · 2 shared papers, 2016–2020 · strength 0.13
  20. Zhi Rong Qian · 4 shared papers, 2013–2016 · strength 0.13
  21. Adetunji T. Toriola · 1 shared paper, 2017 · strength 0.09
  22. Jihye Kim · 1 shared paper, 2020 · strength 0.09
  23. Alison P. Klein · 1 shared paper, 2020 · strength 0.09
  24. Pari V. Pandharipande · 1 shared paper, 2020 · strength 0.09
  25. Chen Hsuan Wu · 3 shared papers, 2013–2014 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.